Welcome

BioInvent is a research-based pharmaceutical company developing innovative antibody drugs to target diseases with unmet clinical need. The Company's pipeline currently includes product candidates for the treatment of cancer, thrombosis and atherosclerosis.

Meet us

Anglonordic Biotech Conference IX, 24 May, 2012, London, United Kingdom
Jefferies 2012 Global Healthcare Conference, 4 - 7 June, 2012, NYC, USA
2012 BIO International Convention, 18 - 21 June, 2012, Boston, USA

Our Pipeline

BioInvent develops antibody-based drugs to tackle conditions where there is a significant need for new treatments. We currently have four antibody therapeutics in development. Find out more »

Press Releases

Latest Share Price

Clinical Trials

BioInvent is currently running a number of early-stage clinical trials with several of its products. Click here to find out more »